Ghosh A K, Majumder M, Steele R, Yaciuk P, Chrivia J, Ray R, Ray R B
Department of Pathology, Saint Louis University, St. Louis, Missouri 63104, USA.
J Biol Chem. 2000 Mar 10;275(10):7184-8. doi: 10.1074/jbc.275.10.7184.
Hepatitis C virus NS5A protein transcriptionally modulates cellular genes and promotes cell growth. NS5A is likely to exert its activity in concert with cellular factor(s). Using a yeast two-hybrid screen, we have demonstrated that NS5A interacts with the C-terminal end of a newly identified cellular transcription factor, SRCAP. The authenticity of this interaction was verified by a mammalian two-hybrid assay, in vitro pull-down experiment, and an in vivo coimmunoprecipitation assay in human hepatoma (HepG2) cells. An in vitro transient transfection assay demonstrated that SRCAP can efficiently activate transcription when recruited by the Gal4 DNA-binding domain to the promoter. However, down-regulation of p21 promoter activity by NS5A was enhanced following ectopic expression of SRCAP. Together these results suggest that the interaction of NS5A and SRCAP may be one of the mechanisms by which NS5A exerts its effect on cell growth regulation contributing to hepatitis C virus-mediated pathogenesis.
丙型肝炎病毒NS5A蛋白可转录调节细胞基因并促进细胞生长。NS5A可能与细胞因子协同发挥其活性。通过酵母双杂交筛选,我们证明NS5A与新鉴定的细胞转录因子SRCAP的C末端相互作用。这种相互作用的真实性通过哺乳动物双杂交试验、体外下拉实验以及人肝癌(HepG2)细胞中的体内共免疫沉淀试验得到验证。体外瞬时转染试验表明,当被Gal4 DNA结合结构域募集到启动子时,SRCAP可以有效激活转录。然而,在异位表达SRCAP后,NS5A对p21启动子活性的下调作用增强。这些结果共同表明,NS5A与SRCAP的相互作用可能是NS5A对细胞生长调节发挥作用从而导致丙型肝炎病毒介导的发病机制的机制之一。